Answers are grounded in this paper and cite their sources.
Review identifies lysosomal alkalinization as a shared mechanism in neurodegenerative diseases and lysosomal storage disorders, suggesting therapeutic possibilities.
Lysosomes are important cellular organelles involved in the recycling of biomolecules in the cell. The acidic intraluminal pH of the lysosome is necessary for the functioning of various hydrolytic enzymes involved in the recycling of biomolecules. Elevated lysosomal pH has been consistently documented in pathological conditions associated with progressive neurodegeneration, including several classical neurodegenerative diseases (e.g., Alzheimer’s disease, Huntington’s disease) and lysosomal storage disorders or LSDs (e.g., Gaucher disease, CLN3 disease). This review focuses on the molecular mechanisms of lysosomal pH regulation, describing the critical roles of vacuolar ATPases and ion channels in maintaining lysosomal pH homeostasis. Further, we highlight how defective acidification of the lysosome can promote common cellular defects linked with both classical neurodegeneration and LSDs. The review also draws a parallel between the pathological consequences of experimentally-induced lysosomal alkalinization and two complex classes of disorders: classical neurodegeneration and LSDs. This comparison raises the possibility that lysosomal pH is one of the multiple shared contributing mechanisms for both conditions and, therefore, a conceivable therapeutic target of classical neurodegeneration and LSDs.
No takes yet. Share an insight, caveat, or question.
Dubey et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: